Club Drugs and Hallucinogens (2019) | Abigail J. Herron, DO
This presentation is part of the Addiction Medicine Review Course 2019, an overview of the core elements of addiction medicine, presented by top experts in the field. Together with the other presentations it can serve as a broad review for clinicians, a review of the basics for newcomers, or a starting point for those preparing to sit for the ABPM Board Examination in Addiction Medicine.
Learners cannot sign up for individual lectures, only for the full Addiction Medicine Review Course 2019. Please contact CSAM (email@example.com) if you have any questions about this online educational offering.
- Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
- Public health officials who want an understanding of the current state of addiction treatment
- Non-physicians who are involved in the treatment of addiction
- Identify signs and symptoms of substance use disorders involving hallucinogens and club drugs
- Recognize the presentation of acute and chronic intoxication
- Describe relevant epidemiology
Abigail J. Herron, DO, FAPA, DFASAM
Abigail J. Herron, DO, is the Vice President for Behavioral Health and the Director of Psychiatry and Addiction Medicine at the Institute for Family Health. She is board certified in adult psychiatry, addiction psychiatry and addiction medicine, and is an Assistant Professor of Psychiatry and Family Medicine at the Icahn School of Medicine at Mt. Sinai. Dr. Herron is a fellow of the American Psychiatric Association and a Distinguished Fellow of the American Society of Addiction Medicine. She graduated from Wesleyan University and the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine. Dr. Herron completed her psychiatry residency at St. Luke's and Roosevelt Hospitals, where she was also chief resident, and a clinical research fellowship in addiction psychiatry at Columbia University and the New York State Psychiatric Institute. Her academic interests include treatment of co-occurring disorders, integrated care, and medical education. She is the co-editor of the Addiction Casebook, and the editor-in-chief of ASAM’s Essentials of Addiction Medicine.
Nothing to disclose
The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credits™, Physicians should only claim credit commensurate with the extent of their participation in the activity.
Continuing education credit is available for psychologists, therapists, substance use counselors, nurses and physician assistants.
(see additional information on page for parent course)
- 1.00 AMA Category 1
- 1.00 Attendance